Drug: infliximab, recombinant Quarter: 2016Q3
Total Drug/Injury Combinations: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| INFLIXIMAB, RECOMBINANT | Off label use | 31 | view events |
| INFLIXIMAB, RECOMBINANT | Product use issue | 29 | view events |
| INFLIXIMAB, RECOMBINANT | Crohn's disease | 27 | view events |
| INFLIXIMAB, RECOMBINANT | Therapeutic response decreased | 27 | view events |
| INFLIXIMAB, RECOMBINANT | Lupus-like syndrome | 23 | view events |
| INFLIXIMAB, RECOMBINANT | Drug ineffective | 19 | view events |
| INFLIXIMAB, RECOMBINANT | Infection | 17 | view events |
| INFLIXIMAB, RECOMBINANT | Infusion related reaction | 16 | view events |
| INFLIXIMAB, RECOMBINANT | Hospitalisation | 13 | view events |
| INFLIXIMAB, RECOMBINANT | Rectal haemorrhage | 12 | view events |
| INFLIXIMAB, RECOMBINANT | Colectomy | 11 | view events |
| INFLIXIMAB, RECOMBINANT | Drug specific antibody present | 11 | view events |
| INFLIXIMAB, RECOMBINANT | Adverse event | 10 | view events |
| INFLIXIMAB, RECOMBINANT | Fatigue | 10 | view events |
| INFLIXIMAB, RECOMBINANT | Pyrexia | 10 | view events |
| INFLIXIMAB, RECOMBINANT | Colitis | 9 | view events |
| INFLIXIMAB, RECOMBINANT | Psoriasis | 9 | view events |
| INFLIXIMAB, RECOMBINANT | Colitis ulcerative | 8 | view events |
| INFLIXIMAB, RECOMBINANT | Histiocytosis haematophagic | 8 | view events |
| INFLIXIMAB, RECOMBINANT | Pneumonia | 8 | view events |
Total Drug/Injury Combinations: 276 Number of Pages: 14
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)